H.R. 842 119th Congress
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
- Health
- Sponsor: Rep. Arrington, Jodey C. [R-TX-19]
- Congress.gov ↗
Latest action, Oct 3, 2025: Reported (Amended) by the Committee on Ways and Means. H. Rept. 119-333, Part I.
How the Senate voted
The Senate hasn't taken a roll call on this bill in the Congresses covered.
338 cosponsors
Sponsored by Rep. Arrington, Jodey C. [R-TX-19] (Republican). Cosponsors by party, House members included:
- Democrats
- Republicans
- Independents
Cosponsors
185 D · 153 R
Referred to: House: Energy and Commerce Committee; House: Ways and Means Committee
Who lobbied on it
Clients whose quarterly lobbying reports named it, each quarter.
The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.
GRAIL LLC
MILLER STRATEGIES, LLC
7 reports
7 reports
GRAIL, INC.
BALLARD SPAHR LLP
7 reports
GRAIL, LLC
TIBER CREEK HEALTH STRATEGIES, INC.
6 reports
ASSOCIATION OF CANCER CARE CENTERS (FKA ASSOCIATION OF COMMUNITY CANCER CENTERS)
5 reports
5 reports
EXACT SCIENCES CORPORATION
ALPINE GROUP PARTNERS, LLC.
5 reports
GRAIL, INC.
AVENUE SOLUTIONS
5 reports
GRAIL, INC.
THE MCMANUS GROUP
5 reports
ILLUMINA, INC.
AVENUE SOLUTIONS
5 reports
5 reports
The top 25 of 41 clients, by reports
| Client | Lobbying firm | Reports | Reports totaling | From | To | Senate |
|---|---|---|---|---|---|---|
| AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) | 7 | $28.6M | Q1 2025 | Q3 2026 | yes | |
| AMERICAN ASSOCIATION OF NURSE PRACTITIONERS | 7 | $2.9M | Q1 2025 | Q3 2026 | yes | |
| GRAIL LLC | MILLER STRATEGIES, LLC | 7 | $0 | Q1 2025 | Q3 2026 | yes |
| GRAIL, INC. | 7 | $3.9M | Q1 2025 | Q3 2026 | yes | |
| GRAIL, INC. | BALLARD SPAHR LLP | 7 | $0 | Q1 2025 | Q3 2026 | yes |
| GRAIL, LLC | TIBER CREEK HEALTH STRATEGIES, INC. | 6 | $0 | Q4 2025 | Q3 2026 | yes |
| ASSOCIATION OF CANCER CARE CENTERS (FKA ASSOCIATION OF COMMUNITY CANCER CENTERS) | 5 | $130K | Q1 2025 | Q1 2026 | yes | |
| EXACT SCIENCES | 5 | $2.2M | Q1 2025 | Q1 2026 | yes | |
| EXACT SCIENCES CORPORATION | ALPINE GROUP PARTNERS, LLC. | 5 | $0 | Q1 2025 | Q1 2026 | yes |
| GRAIL, INC. | AVENUE SOLUTIONS | 5 | $0 | Q1 2025 | Q1 2026 | yes |
| GRAIL, INC. | THE MCMANUS GROUP | 5 | $0 | Q1 2025 | Q1 2026 | yes |
| ILLUMINA, INC. | AVENUE SOLUTIONS | 5 | $0 | Q1 2025 | Q1 2026 | yes |
| INTERNATIONAL ASSOCIATION OF FIRE FIGHTERS | 5 | $973K | Q1 2025 | Q1 2026 | yes | |
| JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A) | 5 | $2.0M | Q4 2025 | Q3 2026 | yes | |
| SYENSQO USA LLC | 5 | $1.4M | Q1 2025 | Q1 2026 | — | |
| THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN | 5 | $570K | Q1 2025 | Q1 2026 | yes | |
| TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GRAIL, LLC | B HALL STRATEGIES, LLC | 5 | $150K | Q4 2025 | Q2 2026 | yes |
| AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC | 4 | $9.1M | Q1 2025 | Q3 2025 | yes | |
| BOEHRINGER INGELHEIM USA CORPORATION | BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC | 4 | $3.5M | Q4 2025 | Q3 2026 | yes |
| GRAIL, INC | ALEXANDER J. BECKLES, L.L.C. | 4 | $0 | Q1 2025 | Q3 2025 | — |
| JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.) | DYKEMA GOSSETT PLLC | 4 | $0 | Q4 2025 | Q1 2026 | yes |
| JOHN HANCOCK LIFE INSURANCE COMPANY (USA) (FKA JOHN HANCOCK FIN. SERVICES, INC.) | COVINGTON & BURLING LLP | 4 | $230K | Q1 2025 | Q3 2025 | yes |
| NATIONAL MINORITY QUALITY FORUM ACTION NETWORK | INTEGRATED SOLUTIONS GROUP | 4 | $190K | Q1 2025 | Q3 2025 | yes |
| BLUECROSS BLUESHIELD OF TENNESSEE | 3 | $780K | Q1 2026 | Q3 2026 | yes | |
| CURING STOMACH CANCER: DEBBIE'S DREAM FOUNDATION | MGD STRATEGIES LLC | 3 | $65K | Q4 2025 | Q1 2026 | yes |